Pfizer affirms FY25 earnings guidance, provides full-year 2026 outlook
Pfizer Inc. (NYSE: PFE) has reaffirmed its earnings outlook for fiscal 2025 and revised revenue guidance. The pharma giant also ...
Sunday, January 11, 2026
Tag: Pfizer
Pfizer Stock: S&P Giant Raises Profit Outlook Even As Third-Quarter Sales Fall
Pfizer (PFE) stock dipped early Tuesday even after the company hiked its 2025 profit guidance, as third-quarter sales and earnings ...
Pfizer hits Novo Nordisk and Metsera with lawsuit amid bidding war
Pfizer has followed through on its threats, filing a lawsuit against both Metsera and Novo Nordisk during a M&A bidding ...
1 Stock to Buy, 1 Stock to Sell This Week: Palantir, Pfizer
ADP jobs report, ISM PMI surveys, and more AI-linked tech earnings will be in focus this week. Palantir is expected ...
Wells Fargo, Pfizer CEOs warn U.S. could lose out to China without innovation
Albert Bourla, CEO of Pfizer, Charlie Scharf, Wells Fargo & Company CEO and Kathy Warden, Northrop Grumman Chair & CEO ...
Pfizer Inc. (PFE) Targets $4.5B in Cost Savings to Fuel R&D and Innovative Therapies
In this article, we will be taking a look at the 10 Best Pharma Stocks to Buy According to Billionaires. ...
Pfizer battles another Paxlovid lawsuit from Enanta
If you don’t succeed at first, try again – in separate regions. That’s the motto Enanta Pharmaceuticals is following, at ...
Pfizer – PFE: Tanzen die Pharma-Bullen schon wieder auf dem Parkett?
Großinvestoren stocken auf! Pfizer-Aktie (PFE) mit Golden Cross & Bullenflagge zum 20er-EMA! JETZT einsteigen? Pfizer (PFE) – ISIN US0640581007 Rückblick: ...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.